ENvue Medical, Inc. (FEED) Form 10-Q — May 18, 2026
ENvue Medical reported a net loss of $3.8 million for the first quarter of 2026, driven by a 36% decline in revenue to $653,000 and significant operating expenses. The company explicitly stated that these conditions raise substantial doubt about its ability to continue as a going concern for the next twelve months, citing insufficient cash reserves to fund operations without additional financing. The financial results were heavily impacted by non-cash charges, including a $17 million deemed dividend resulting from down-round adjustments to its Series H Preferred Stock conversion price.
Key figures
- Revenue
- 653000
- Total Debt
- 1080000
- Total Assets
- 39871000
- Cash Position
- 2235000
- Warrant liability
- 824000
- Shares outstanding
- 6091840
- Arbitration liability
- 2285000
Price after filing
Close on the filing date to close N calendar days later (from $1.01). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.